Find a Tender
planning
Official procurement procedure
Medtech Commercial Strategy 2026
Medical equipments
Pharmaceutical products
Location not published
Published value
£0
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Department of Health & Social Care: "Medtech Commercial Strategy 2026". Published status: planning. Published value: £0. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Department of Health & Social Care | Scope & Categories | Not published | Submission Window | planning No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £0 |
Bidder Intelligence · Authority Profile: Department of Health & Social Care
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Department of Health & Social Care. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
8.6Bids / Report
Supplier ConcentrationHigh Concentration
Wavemaker LimitedTop vendor: 97.8% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 76 active published awards; 5 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Wavemaker Limited | 1 win | £244,700,000 |
| The Breastfeeding Network | 1 win | £4,978,957 |
| Severn Trent Water Limited | 1 win | £320,841 |
| Population Health Ltd | 1 win | £150,495 |
| Yorkshire Water Limited | 1 win | £59,425 |
Procedure terms
Contracting AuthorityDepartment of Health & Social Care | Procedure methodNot published | Procurement categoryNot published |
Statusplanning | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published6 Mar 2026, 15:55 GMT | Last source update6 Mar 2026, 15:55 GMT | Recurring procurementNot published |
ClassificationMedical equipments, Pharmaceutical products | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-06498a | ||
What is being bought
NHS England, the Department of Health and Social Care (DHSC), and NHS Supply Chain are jointly developing a MedTech Commercial Strategy. The aim is to bring cohesion, reduce duplication, improve efficiency, and create a unified approach that supports innovation and better patient outcomes across the full commercial lifecycle.
What changed
From the official release history
- Official notice release published
6 Mar 2026, 15:55 GMT - Published value updated to £0
5 Feb 2026, 17:53 GMT - Status changed to planning
5 Feb 2026, 17:53 GMT - Official notice release published
5 Feb 2026, 17:53 GMT - Buyer information updated
5 Feb 2026, 17:53 GMT - Published tender amendment
Not publishedExtension of response window
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedplanningPublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Pipeline notice
6 Mar 2026, 15:55 GMT - Procedure published
6 Mar 2026, 15:55 GMT - engagement
6 Mar 2026, 23:59 GMT · scheduledPlease note the response window for this engagement has been extended until 17:00 on 13th March 2026. MedTech plays a vital role in enabling the NHS to deliver high quality, innovative and patient centred care. From diagnostics and treatment pathways to digital transformation and earlier intervention, MedTech is central to achieving the ambitions set out in the 10 Year Health Plan. However, the current commercial landscape is fragmented, creating challenges for buyers in navigating the market, delivering value, and supporting consistent adoption at scale. With annual MedTech spend at approximately £13 billion, there is a significant opportunity for the NHS to both improve outcomes and productivity, but also to align with wider government priorities for innovation, growth and the UK life sciences sector. To address these challenges, NHS England, the Department of Health and Social Care (DHSC), and NHS Supply Chain are jointly developing a MedTech Commercial Strategy. The aim is to bring cohesion, reduce duplication, improve efficiency, and create a unified approach that supports innovation and better patient outcomes across the full commercial lifecycle. The Medtech Commercial Strategy seeks to: • Simplify and strengthen commercial pathways • Improve value for money and patient outcomes • Provide clearer expectations for suppliers • Reduce duplication and unwarranted variation • Align with wider government priorities for innovation and growth • Support more consistent and informed decision making across the NHS This market engagement is being issued on Thursday 5th February 2026. The closing date for responses is on: 12:00pm, Friday 13th March 2026. Please respond to the questions listed in the survey using this link: https://forms.office.com/e/J46XXPTNv8 A PDF version of the survey is available here: https://atamis-1928.my.salesforce.com/sfc/p/0O000000rwim/a/Pz00000HFe4z/cDoawL9.YLr.PHsYuO5_t4H5m0KcGk95CabcRCmcI_8 Please submit responses via the Forms survey link only. This engagement is designed to gather feedback from organisations in the Medtech sector to directly shape the Medtech Commercial Strategy. The survey seeks honest and practical reflections on what currently works well, the challenges faced, and where change is most needed. To support the survey, we are running information and engagement webinars. The webinars will share the purpose, scope, ambition and early discovery insights of the strategy, with an interactive engagement exercise to inform the discovery phase. The webinars are taking place on the dates below. Please register for one of the webinars using the links below: Thursday 12th February 3pm-4pm: https://events.teams.microsoft.com/event/f889be9a-b16c-4a9a-aeb6-d32ab366f20e@37c354b2-85b0-47f5-b222-07b48d774ee3 Thursday 10th March 3pm-4pm - https://events.teams.microsoft.com/event/ce796664-4e20-4978-a201-603aa97d7341@37c354b2-85b0-47f5-b222-07b48d774ee3 During the webinars, we will: • Provide an overview of the objectives and scope of the MedTech Commercial Strategy • Share how this work will help shape future NHS commercial direction • Set out key routes for engagement • Run an interactive session to gather views on opportunities, challenges, and potential improvements This notice does not constitute a call for competition. The aim of this engagement is to inform the development of the Medtech Commercial Strategy. For further guidance on how to complete the questionnaire and information about the market engagement please use this link: https://atamis-1928.my.salesforce.com/sfc/p/0O000000rwim/a/Pz00000HFNAb/aUZ.3KC0EH8E6tt3YlKb4xCXeoxug7qwUCQpxx97Xzw
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Department of Health & Social Care
Contracting authority GB-PPON-PMQG-9965-CHZRDocuments (1)
Official links; attachments are not copied
- 6 Mar 2026, 15:55 GMT
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleNot published |